CureVac N.V.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
13.18
-0.56
(-4.076%)
Volume:
220,684
52 week range:
12.39 - 75.68
Market Cap:
2.466B
Company Description:
CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.